Sharing Pathogenetic Mechanisms between Acute Myocardial Infarction and Alzheimer's Disease as Shown by Partially Overlapping of Gene Variant Profiles

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Alzheimer's Disease

• Publication date

  2011-02-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3233/JAD-2010-090871PMID 21098980
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

  2011cited by this paper
• Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

  2009cited by this paper
• Parkinson's Disease and Low Frequency Alleles Found Together Throughout LRRK2

  2009cited by this paper
• Earlier Onset of Alzheimer's Disease: Risk Polymorphisms Within PRNP, PRND, CYP46, and APOE Genes

  2009cited by this paper
• Elevated plasma levels of alpha-1-anti-chymotrypsin in age-related cognitive decline and Alzheimer's disease: a potential therapeutic target.

  2008cited by this paper
• Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease

  2007cited by this paper
• Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation.

  2007cited by this paper
• Susceptibility groups for Alzheimer's disease (OPTIMA cohort): integration of gene variants and biochemical factors.

  2007cited by this paper
• Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers.

  2007cited by this paper
• Cardiovascular risk factors for Alzheimer's disease.

  2007cited by this paper
• Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?

  2007cited by this paper
• Acute Myocardial Infarction and Proinflammatory Gene Variants

  2007cited by this paper
• Systemic inflammation, infection, ApoE alleles, and Alzheimer disease: a position paper.

  2007cited by this paper
• Circle of Willis atherosclerosis: association with Alzheimer’s disease, neuritic plaques and neurofibrillary tangles

  2006cited by this paper
• How do heart disease and stroke become risk factors for Alzheimer's disease?

  2006cited by this paper
• Cardiovascular disease and Alzheimer's disease: common links

  2006cited by this paper
• Membership in Genetic Groups Predicts Alzheimer Disease

  2006cited by this paper
• Cognitive frailty: Predementia syndrome and vascular risk factors.

  2006cited by this paper
• Parkinson's Disease in Relation to Pesticide Exposure and Nuclear Encoded Mitochondrial Complex I Gene Variants

  2006cited by this paper
• Impaired regulation of immune responses in cognitive decline and Alzheimer’s disease: lessons from genetic association studies

  2006cited by this paper
• Multilocus Genotypes Spanning Estrogen Metabolism Associated with Breast Cancer and Fibroadenoma

  2006cited by this paper
• Interaction of cardiovascular disease and neurodegeneration: transcranial Doppler ultrasonography and Alzheimer's disease

  2006cited by this paper
• Does Apolipoprotein E Polymorphism Determine the Survivability of Vascular Accidents at Advanced Ages? Implications for Mortality Differentials

  2006cited by this paper
• Epidemiology of heart failure and left ventricular systolic dysfunction after acute myocardial infarction: prevalence, clinical characteristics, and prognostic importance.

  2006cited by this paper
• Pro-inflammatory cytokines in acute coronary syndromes: from bench to bedside.

  2006cited by this paper
• Cardiovascular emergencies in the elderly.

  2006cited by this paper
• Atherosclerosis and AD

  2005cited by this paper
• Dementia and Alzheimer's Disease Incidence in Relationship to Cardiovascular Disease in the Cardiovascular Health Study Cohort

  2005cited by this paper
• Homocysteine and folate as risk factors for dementia and Alzheimer disease.

  2005cited by this paper
• Statin therapy for prevention and treatment of acute and chronic cardiovascular disease: update on recent trials and metaanalyses

  2005cited by this paper
• Genetic evidence for a distinct subtype of schizophrenia characterized by pervasive cognitive deficit.

  2005cited by this paper
• Long-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population

  2005cited by this paper
• Cardiovascular Damage in Alzheimer Disease: Autopsy Findings From the Bryan ADRC

  2005cited by this paper
• Statins — a cure-all for the brain?

  2005cited by this paper
• Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms

  2005cited by this paper
• A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease.

  2005cited by this paper
• Interleukin‐6 gene polymorphism is an age‐dependent risk factor for myocardial infarction in men

  2005cited by this paper
• Novel ‘inflammatory plaque’ pathology in presenilin‐1 Alzheimer's disease

  2005cited by this paper
• Nonsteroidal Antiinflammatory Drugs and the Risk of Myocardial Infarction in the General Population

  2004cited by this paper
• Genetic variation in apolipoprotein D and Alzheimer’s disease

  2004cited by this paper
• Apolipoprotein E phenotypes in patients with myocardial infarction

  2004cited by this paper
• Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease

  2004cited by this paper
• Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease

  2004cited by this paper
• Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins.

  2004cited by this paper
• The concomitant presence of polymorphic alleles of interleukin-1beta, interleukin-6 and apolipoprotein E is associated with an increased risk of myocardial infarction in elderly men. Results from a pilot study.

  2004cited by this paper
• Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease

  2004cited by this paper
• Brain immune responses cognitive decline and dementia: relationship with phenotype expression and genetic background.

  2003cited by this paper
• Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease

  2003cited by this paper
• Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain.

  2003cited by this paper
• Advanced glycation endproducts and pro‐inflammatory cytokines in transgenic Tg2576 mice with amyloid plaque pathology

  2003cited by this paper
• Intrathecal inflammation precedes development of Alzheimer’s disease

  2003cited by this paper
• Early inflammation and dementia: A 25‐year follow‐up of the Honolulu‐Asia aging study

  2002cited by this paper
• Genetic variation at the interleukin-1 locus is a determinant of changes in soluble endothelial factors in patients with acute coronary syndromes.

  2002cited by this paper
• Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies

  2002cited by this paper
• In the Elderly, Interleukin-6 Plasma Levels and the −174G>C Polymorphism Are Associated With the Development of Cardiovascular Disease

  2002cited by this paper
• Acute-phase reactants and coronary heart disease.

  2002cited by this paper
• Grade‐of‐membership sibpair linkage analysis maps IDDM11 to chromosome 14q24.3–q31

  2001cited by this paper
• The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men.

  2001cited by this paper
• High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease.

  2001cited by this paper
• Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease.

  2001cited by this paper
• Gene polymorphism affecting α1‐antichymotrypsin and interleukin‐1 plasma levels increases Alzheimer's disease risk

  2000cited by this paper
• Density profiles of Alzheimer disease regional brain pathology for the huddinge brain bank: pattern recognition emulates and expands upon Braak staging.

  2000cited by this paper
• Association of early‐onset Alzheimer's disease with an interleukin‐1α gene polymorphism

  2000cited by this paper
• Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction.

  2000cited by this paper
• Role of lipid, apolipoprotein levels and apolipoprotein E genotype in young Italian patients with myocardial infarction.

  1999cited by this paper
• Increased levels of α-1-antichymotrypsin in brains of patients with Alzheimer's disease correlate with activated astrocytes and are affected by APOE 4 genotype

  1998cited by this paper
• Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities.

  1997cited by this paper
• Chronic disability trends in elderly United States populations: 1982-1994.

  1997cited by this paper
• In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis.

  1996cited by this paper
• Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women.

  1995cited by this paper
• Symptom profiles of psychiatric disorders based on graded disease classes: an illustration using data from the WHO International Pilot Study of Schizophrenia

  1994cited by this paper
• Cerebrospinal Fluid of Patients with Senile Dementia of Alzheimer's Type Shows an Increased Inhibition of α-Chymotrypsin

  1994cited by this paper
• Genetic heterogeneity in Alzheimer's disease: A grade of membership analysis

  1993cited by this paper
• Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease.

  1993cited by this paper
• Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

  1993cited by this paper
• Multivariate Procedures to Describe Clinical Staging of Melanoma

  1991cited by this paper
• Alzheimer's disease and Parkinson's disease

  1988cited by this paper
• Association of apolipoprotein E polymorphism, low-density lipoprotein cholesterol, and coronary artery disease.

  1986cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• Mathematical typology: a grade of membership technique for obtaining disease definition.

  1978cited by this paper
• Clinical Pure Types as a Fuzzy Partition

  1974cited by this paper

• A Module-Level Polygenic Risk Score-Based NetWAS Framework for Identifying AD Genetic Modules Mediated by Amygdala: An ADNI Study

  2025cites this paper
• Machine Learning Approach to Identify Case-Control Studies on ApoE Gene Mutations Linked to Alzheimer’s Disease in Italy

  2024cites this paper
• Cholinesterase inhibitors are associated with reduced mortality in patients with Alzheimer's disease and previous myocardial infarction.

  2024cites this paper
• Artificial Intelligence and Circulating Cell-Free DNA Methylation Profiling: Mechanism and Detection of Alzheimer’s Disease

  2022cites this paper
• Inflammasome-mediated neurodegeneration following heart disease

  2021cites this paper
• Reappraisal of FDA approved drugs against Alzheimer’s disease based on differential gene expression and protein interaction network analysis: an in silico approach

  2020cites this paper
• Development of Alzheimer's Disease after Myocardial Infarction.

  2020cites this paper
• On entropy and information in gene interaction networks

  2018cites this paper
• Mining high-level brain imaging genetic associations

  2018cites this paper
• Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN

  2017cites this paper
• SNP_TATA_Comparator: genomewide landmarks for preventive personalized medicine.

  2017cites this paper
• Candidate SNP Markers of Familial and Sporadic Alzheimer's Diseases Are Predicted by a Significant Change in the Affinity of TATA-Binding Protein for Human Gene Promoters

  2017cites this paper
• Tissue‐specific network‐based genome wide study of amygdala imaging phenotypes to identify functional interaction modules

  2017cites this paper
• Network analysis of human diseases using Korean nationwide claims data

  2016cites this paper
• Endothelial cell dysfunction and cardiac hypertrophy in the STOX1 model of preeclampsia

  2016cites this paper
• A New Risk Chart of Acute Myocardial Infarction in Men by an Innovative Algorithm: A Pilot Study

  2015cites this paper
• A New Risk Chart for Acute Myocardial Infarction by a Innovative Algoritm

  2015cites this paper
• Impact of acetylcholinesterase inhibitors on the occurrence of acute coronary syndrome in patients with dementia

  2015cites this paper
• Alzheimer ’ s disease and infections , where we 3 stand and where we go 4

  2014cites this paper
• Alzheimer’s disease and infections, where we stand and where we go

  2014cites this paper
• Adhesion molecules in CNS disorders: biomarker and therapeutic targets.

  2013cites this paper
• Human herpes virus and Alzheimer’s disease

  2013cites this paper
• Study findings hard to interpret.

  2012cites this paper
• Association Between Interleukin-10 Polymorphisms and Alzheimer's Disease: A Systematic Review and Meta-Analysis

  2012cites this paper
• Gene Signature in Alzheimer's Disease and Environmental Factors: The Virus Chronicle

  2011cites this paper
• Reduced plasma levels of P-selectin and L-selectin in a pilot study from Alzheimer disease: relationship with neuro-degeneration

  2011cites this paper